Sawhney Roger
SEC insider (Form 3/4/5 filer). CIK 0001858748. Director at Arbutus Biopharma Corp (ABUS) and 2 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WARMINSTER, PA.
Companies Sawhney Roger has filed insider reports for
- Arbutus Biopharma Corp (ABUS): Director
- Adlai Nortye Ltd. (ANL): Director
- ACTUATE THERAPEUTICS, INC. (ACTU): Director
Sawhney Roger
CIK: 0001858748
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 1, 2026ABUS
Arbutus Biopharma Corp
DispositionDirect17.1K shares at avg. $5.00$86K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
ExerciseDirect52.5K shares at avg. $3.34$175K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
ExerciseDirect78.8K shares at avg. $4.24$334K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
Tax PaymentDirect100.5K shares at avg. $5.07$510K - Jun 8, 2026ABUS
Arbutus Biopharma Corp
AwardDirectStock Option (Right to Buy)
78.8K shares- - May 21, 2026ACTU
ACTUATE THERAPEUTICS, INC.
AwardDirectStock Options
15K shares- - Aug 4, 2025ABUS
Arbutus Biopharma Corp
AwardDirectStock Option (Right to Buy)
157.6K shares- - May 22, 2025ACTU
ACTUATE THERAPEUTICS, INC.
AwardDirectStock Options
15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  ABUS Arbutus Biopharma Corp | Disposition | 17,142 | $5.00 | $85,710 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Exercise | 52,533 | $3.34 | $175,460 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Exercise | 78,800 | $4.24 | $334,112 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Tax Payment | 100,508 | $5.07 | $509,576 | Direct |
| Jun 8, 2026 | ABUS Arbutus Biopharma Corp | Award Stock Option (Right to Buy) | 78,800 | - | - | Direct |
| May 21, 2026 |  ACTU ACTUATE THERAPEUTICS, INC. | Award Stock Options | 15,000 | - | - | Direct |
| Aug 4, 2025 | ABUS Arbutus Biopharma Corp | Award Stock Option (Right to Buy) | 157,600 | - | - | Direct |
| May 22, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | Award Stock Options | 15,000 | - | - | Direct |
1-8 of 8 transactions